Mitoxantrone
Novantrone (mitoxantrone) is a small molecule pharmaceutical. Mitoxantrone was first approved as Novantrone on 1987-12-23. It is used to treat breast neoplasms, lymphoma, multiple sclerosis, myeloid leukemia acute, and pain amongst others in the USA. It is known to target DNA topoisomerase 2-alpha and DNA topoisomerase 2-beta.
| Trade Name | Novantrone |
|---|---|
| Common Name | Mitoxantrone |
| Indication | breast neoplasms, lymphoma, multiple sclerosis, myeloid leukemia acute, pain, prostatic neoplasms, sarcoma |
| Drug Class | Antineoplastics, anthraquinone derivatives |
